Compass Retained Earnings from 2010 to 2025

CMPX Stock

USD 2.11 0.06 2.76%

Compass Therapeutics Retained Earnings yearly trend continues to be fairly stable with very little volatility. Retained Earnings are likely to outpace its year average in 2025. Retained Earnings is the cumulative amount of net income that Compass Therapeutics retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2018-06-30

Previous Quarter

-349.7 M

Current Value

-364.7 M

Quarterly Volatility

121.8 M

Covid

Check Compass Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Compass Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 7.7 M or Interest Income of 7.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.26. Compass financial statements analysis is a perfect complement when working with Compass Therapeutics Valuation or Volatility modules.

Check out the analysis of Compass Therapeutics Correlation against competitors.

For more information on how to buy Compass Stock please use our How to Invest in Compass Therapeutics guide.

Latest Compass Therapeutics' Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Compass Therapeutics over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Compass Therapeutics' Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Compass Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (364.68 M)

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

Compass Retained Earnings Regression Statistics

	Arithmetic Mean	(161,914,678)
	Geometric Mean	135,945,240
	Coefficient Of Variation	(65.39)
	Mean Deviation	90,408,682
	Median	(87,164,000)
	Standard Deviation	105,871,977
	Sample Variance	11208.9T
	Range	277.5M
	R-Value	(0.87)
	Mean Square Error	2958T
	R-Squared	0.75
	Significance	0.000013
	Slope	(19,305,707)
	Total Sum of Squares	168133.1T

Compass Retained Earnings History

	2025	-346.4 M
	2024	-364.7 M
	2023	-315.3 M
	2022	-272.8 M
	2021	-233.6 M
	2020	-151.4 M
	2019	-121.9 M

Other Fundumenentals of Compass Therapeutics

Retained Earnings Total Equity

Compass Therapeutics Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Property Plant Equipment	Long Term Debt Total	Capital Surpluse	Net Receivables
Total Assets		0.93	0.89	0.6	-0.19	-0.83	0.68	-0.77	-0.79	0.93	0.72	1.0	-0.81	1.0	-0.85	-0.81	-0.49	-0.31	0.92	-0.31
Total Stockholder Equity	0.93		0.96	0.8	-0.17	-0.89	0.55	-0.94	-0.95	1.0	0.9	0.93	-0.95	0.93	-0.65	-0.95	-0.67	-0.34	0.92	-0.34
Net Tangible Assets	0.89	0.96		0.76	-0.04	-0.97	0.55	-0.95	-0.95	0.96	0.88	0.89	-0.95	0.89	-0.7	-0.95	-0.74	-0.59	0.94	-0.59
Current Deferred Revenue	0.6	0.8	0.76		0.02	-0.78	0.19	-0.88	-0.85	0.8	0.97	0.61	-0.75	0.61	-0.26	-0.75	-0.73	-0.25	0.74	-0.25
Net Debt	-0.19	-0.17	-0.04	0.02		-0.1	0.36	0.08	0.11	-0.17	-0.04	-0.18	0.16	-0.18	0.2	0.16	-0.54	-0.27	0.01	-0.27
Retained Earnings	-0.83	-0.89	-0.97	-0.78	-0.1		-0.54	0.91	0.9	-0.89	-0.87	-0.83	0.87	-0.83	0.7	0.87	0.77	0.66	-0.95	0.66
Accounts Payable	0.68	0.55	0.55	0.19	0.36	-0.54		-0.37	-0.41	0.55	0.31	0.68	-0.45	0.69	-0.61	-0.45	-0.5	-0.15	0.63	-0.15
Long Term Debt	-0.77	-0.94	-0.95	-0.88	0.08	0.91	-0.37		1.0	-0.94	-0.96	-0.78	0.96	-0.78	0.46	0.96	0.79	0.47	-0.84	0.47
Total Liab	-0.79	-0.95	-0.95	-0.85	0.11	0.9	-0.41	1.0		-0.95	-0.94	-0.8	0.98	-0.79	0.48	0.98	0.77	0.45	-0.83	0.45
Net Invested Capital	0.93	1.0	0.96	0.8	-0.17	-0.89	0.55	-0.94	-0.95		0.9	0.93	-0.95	0.93	-0.65	-0.95	-0.67	-0.33	0.92	-0.33
Short Long Term Debt	0.72	0.9	0.88	0.97	-0.04	-0.87	0.31	-0.96	-0.94	0.9		0.73	-0.88	0.72	-0.38	-0.88	-0.77	-0.34	0.84	-0.34
Total Current Assets	1.0	0.93	0.89	0.61	-0.18	-0.83	0.68	-0.78	-0.8	0.93	0.73		-0.82	1.0	-0.83	-0.82	-0.51	-0.3	0.92	-0.3
Capital Stock	-0.81	-0.95	-0.95	-0.75	0.16	0.87	-0.45	0.96	0.98	-0.95	-0.88	-0.82		-0.82	0.52	1.0	0.72	0.45	-0.82	0.45
Net Working Capital	1.0	0.93	0.89	0.61	-0.18	-0.83	0.69	-0.78	-0.79	0.93	0.72	1.0	-0.82		-0.84	-0.82	-0.5	-0.3	0.92	-0.3
Short Term Debt	-0.85	-0.65	-0.7	-0.26	0.2	0.7	-0.61	0.46	0.48	-0.65	-0.38	-0.83	0.52	-0.84		0.52	0.18	0.45	-0.8	0.45
Common Stock	-0.81	-0.95	-0.95	-0.75	0.16	0.87	-0.45	0.96	0.98	-0.95	-0.88	-0.82	1.0	-0.82	0.52		0.72	0.45	-0.82	0.45
Property Plant Equipment	-0.49	-0.67	-0.74	-0.73	-0.54	0.77	-0.5	0.79	0.77	-0.67	-0.77	-0.51	0.72	-0.5	0.18	0.72		0.52	-0.65	0.52
Long Term Debt Total	-0.31	-0.34	-0.59	-0.25	-0.27	0.66	-0.15	0.47	0.45	-0.33	-0.34	-0.3	0.45	-0.3	0.45	0.45	0.52		-0.47	1.0
Capital Surpluse	0.92	0.92	0.94	0.74	0.01	-0.95	0.63	-0.84	-0.83	0.92	0.84	0.92	-0.82	0.92	-0.8	-0.82	-0.65	-0.47		-0.47
Net Receivables	-0.31	-0.34	-0.59	-0.25	-0.27	0.66	-0.15	0.47	0.45	-0.33	-0.34	-0.3	0.45	-0.3	0.45	0.45	0.52	1.0	-0.47

Click cells to compare fundamentals

About Compass Therapeutics Financial Statements

Compass Therapeutics investors use historical fundamental indicators, such as Compass Therapeutics' Retained Earnings, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Compass Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Retained Earnings	-364.7 M	-346.4 M
Retained Earnings Total Equity	-245.5 M	-257.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Compass Stock Analysis

When running Compass Therapeutics' price analysis, check to measure Compass Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Therapeutics is operating at the current time. Most of Compass Therapeutics' value examination focuses on studying past and present price action to predict the probability of Compass Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Therapeutics' price. Additionally, you may evaluate how the addition of Compass Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC